| Hepatitis C virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature: implications for risks of transmission E Paintsil, M Binka, A Patel, BD Lindenbach, R Heimer The Journal of infectious diseases 209 (8), 1205-1211, 2014 | 136 | 2014 |
| Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort C Rossi, ZA Butt, S Wong, JA Buxton, N Islam, A Yu, M Darvishian, ... Journal of hepatology 69 (5), 1007-1014, 2018 | 126 | 2018 |
| The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H M Binka, M Ooms, M Steward, V Simon Journal of virology 86 (1), 49-59, 2012 | 105 | 2012 |
| The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: impact of direct acting antivirals SR Bartlett, A Yu, N Chapinal, C Rossi, Z Butt, S Wong, M Darvishian, ... Liver International 39 (12), 2261-2272, 2019 | 86 | 2019 |
| Vif proteins of human and simian immunodeficiency viruses require cellular CBFβ to degrade APOBEC3 restriction factors JF Hultquist, M Binka, RS LaRue, V Simon, RS Harris Journal of virology 86 (5), 2874-2877, 2012 | 80 | 2012 |
| Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretrovirals S Fourati, I Malet, M Binka, S Boukobza, M Wirden, S Sayon, A Simon, ... Aids 24 (15), 2313-2321, 2010 | 70 | 2010 |
| VP5* rearranges when rotavirus uncoats JD Yoder, SD Trask, PT Vo, M Binka, N Feng, SC Harrison, HB Greenberg, ... Journal of virology 83 (21), 11372-11377, 2009 | 54 | 2009 |
| Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study NZ Janjua, S Wong, Y Abdia, D Jeong, T Buller-Taylor, PA Adu, H Samji, ... Journal of Hepatology 75 (5), 1049-1057, 2021 | 48 | 2021 |
| The impact of SVR from direct‐acting antiviral‐and interferon‐based treatments for HCV on hepatocellular carcinoma risk NZ Janjua, S Wong, M Darvishian, ZA Butt, A Yu, M Binka, M Alvarez, ... Journal of viral hepatitis 27 (8), 781-793, 2020 | 45 | 2020 |
| The resistance of human APOBEC3H to HIV-1 NL4-3 molecular clone is determined by a single amino acid in Vif M Ooms, M Letko, M Binka, V Simon PloS one 8 (2), e57744, 2013 | 42 | 2013 |
| Association of COVID-19 infection with incident diabetes Z Naveed, HAV García, S Wong, J Wilton, G McKee, B Mahmood, M Binka, ... JAMA Network Open 6 (4), e238866-e238866, 2023 | 35 | 2023 |
| Assessment of treatment strategies to achieve hepatitis C elimination in Canada using a validated model M Binka, NZ Janjua, J Grebely, C Estes, D Schanzer, JA Kwon, ... JAMA network open 3 (5), e204192-e204192, 2020 | 34 | 2020 |
| BC Hepatitis Testers Cohort Team. Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort C Rossi, ZA Butt, S Wong, JA Buxton, N Islam, A Yu, M Darvishian, ... J Hepatol 69 (5), 1007-14, 2018 | 32 | 2018 |
| Survival of hepatitis C virus in syringes is dependent on the design of the syringe-needle and dead space volume M Binka, E Paintsil, A Patel, BD Lindenbach, R Heimer PLoS One 10 (11), e0139737, 2015 | 32 | 2015 |
| Real-world effectiveness of sofosbuvir/velpatasvir for treatment of chronic hepatitis C in British Columbia, Canada: a population-based cohort study J Wilton, S Wong, A Yu, A Ramji, D Cook, ZA Butt, M Alvarez, M Binka, ... Open Forum Infectious Diseases 7 (3), ofaa055, 2020 | 30 | 2020 |
| Loss to follow‐up: a significant barrier in the treatment cascade with direct‐acting therapies M Darvishian, S Wong, M Binka, A Yu, A Ramji, EM Yoshida, J Wong, ... Journal of viral hepatitis 27 (3), 243-260, 2020 | 29 | 2020 |
| Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations C Rossi, D Jeong, S Wong, G McKee, ZA Butt, J Buxton, J Wong, ... Journal of hepatology 71 (6), 1116-1125, 2019 | 26 | 2019 |
| Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada M Binka, ZA Butt, S Wong, M Chong, JA Buxton, N Chapinal, A Yu, ... World Journal of Gastroenterology 24 (11), 1216, 2018 | 25 | 2018 |
| HCV reinfection rates after cure or spontaneous clearance among HIV‐infected and uninfected men who have sex with men PA Adu, C Rossi, M Binka, S Wong, J Wilton, J Wong, ZA Butt, S Bartlett, ... Liver International 41 (3), 482-493, 2021 | 23 | 2021 |
| Concurrent hepatitis C and B virus and human immunodeficiency virus infections are associated with higher mortality risk illustrating the impact of syndemics on health outcomes ZA Butt, S Wong, C Rossi, M Binka, J Wong, A Yu, M Darvishian, ... Open forum infectious diseases 7 (9), ofaa347, 2020 | 20 | 2020 |
